20
Participants
Start Date
April 25, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2026
Metformin
Participants will receive either 2700mg of metformin/day (1350mg twice a day) or 2000mg of metformin/day (1000mg twice a day, standard of care). The study intervention will be blinded to the participants as they will receive the same number of pills (4 pills of the same size) regardless of whether they are in the intervention arm or control arm .
RECRUITING
UCSF Benioff Children's Hospital San Francisco, Madison Clinic for Pediatric Diabetes, San Francisco
RECRUITING
UCSF Benioff Children's Hospital Oakland, Pediatric Diabetes Clinic, Oakland
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
University of California, San Francisco
OTHER